Departments of Human Genetics and Pediatrics, McGill University, Research Institute of the McGill University Health Center, Montreal, Quebec, Canada.
Fels Institute for Cancer Research and Molecular Biology, Temple University, Lewis Katz School of Medicine, Philadelphia, PA, USA.
J Nutr Biochem. 2021 Feb;88:108554. doi: 10.1016/j.jnutbio.2020.108554. Epub 2020 Nov 19.
Food fortification with folic acid and increased use of vitamin supplements have raised concerns about high folic acid intake. We previously showed that high folic acid intake was associated with hepatic degeneration, decreased levels of methylenetetrahydrofolate reductase (MTHFR), lower methylation potential, and perturbations of lipid metabolism. MTHFR synthesizes the folate derivative for methylation reactions. In this study, we assessed the possibility that high folic acid diets, fed to wild-type and Mthfr mice, could alter DNA methylation and/or deregulate hepatic cholesterol homeostasis. Digital restriction enzyme analysis of methylation in liver revealed DNA hypomethylation of a CpG in the lipolysis-stimulated lipoprotein receptor (Lsr) gene, which is involved in hepatic uptake of cholesterol. Pyrosequencing confirmed this methylation change and identified hypomethylation of several neighboring CpG dinucleotides. Lsr expression was increased and correlated negatively with DNA methylation and plasma cholesterol. A putative binding site for E2F1 was identified. ChIP-qPCR confirmed reduced E2F1 binding when methylation at this site was altered, suggesting that it could be involved in increasing Lsr expression. Expression of genes in cholesterol synthesis, transport or turnover (Abcg5, Abcg8, Abcc2, Cyp46a1, and Hmgcs1) was perturbed by high folic acid intake. We also observed increased hepatic cholesterol and increased expression of genes such as Sirt1, which might be involved in a rescue response to restore cholesterol homeostasis. Our work suggests that high folic acid consumption disturbs cholesterol homeostasis in liver. This finding may have particular relevance for MTHFR-deficient individuals, who represent ~10% of many populations.
叶酸强化和维生素补充剂的使用增加引起了人们对高叶酸摄入的担忧。我们之前的研究表明,高叶酸摄入与肝退化、亚甲基四氢叶酸还原酶 (MTHFR) 水平降低、较低的甲基化潜能以及脂质代谢紊乱有关。MTHFR 合成用于甲基化反应的叶酸衍生物。在这项研究中,我们评估了高叶酸饮食(喂食给野生型和 Mthfr 小鼠)是否可能改变 DNA 甲基化和/或扰乱肝胆固醇稳态的可能性。肝脏中甲基化的数字限制性内切酶分析显示,脂肪分解刺激脂蛋白受体 (Lsr) 基因中的一个 CpG 发生 DNA 低甲基化,该基因参与肝内胆固醇摄取。焦磷酸测序证实了这种甲基化变化,并确定了几个相邻 CpG 二核苷酸的低甲基化。Lsr 表达增加,并与 DNA 甲基化和血浆胆固醇呈负相关。鉴定出一个涉及 E2F1 结合的假定结合位点。ChIP-qPCR 证实当该位点的甲基化改变时,E2F1 结合减少,表明它可能参与增加 Lsr 表达。胆固醇合成、转运或周转的基因(Abcg5、Abcg8、Abcc2、Cyp46a1 和 Hmgcs1)的表达受到高叶酸摄入的干扰。我们还观察到肝胆固醇增加和基因表达增加,如 Sirt1,这可能涉及到恢复胆固醇稳态的挽救反应。我们的工作表明,高叶酸摄入扰乱了肝内的胆固醇稳态。这一发现对于 MTHFR 缺乏的个体尤其重要,因为他们在许多人群中占约 10%。